RESPONSIBLE CORPORATIONS IN AN EVER-CHANGING WORLD
Taiho Oncology Europe GmbH strives to make a positive contribution to society and the environment. We support our local communities through charitable endeavors, and we work proactively to protect the environment by minimizing the environmental impact in every aspect of our work – from research and development to production, distribution, marketing, and disposal.
Furthermore, as a member of Otsuka Holdings, we are part of a group of companies that pursues initiatives that are shaped by mutual respect and open communication with all stakeholders, including customers and business partners in the countries and regions where we do business.
MAKING A POSITIVE CONTRIBUTION
“We are proud to support patients through partnerships with organizations that share our company’s mission to improve awareness, prevention and access to quality care for cancer patients and the community at risk.”
REACHING PATIENTS FAR AND WIDE
In addition to advancing patient care through innovation, Taiho Oncology is committed to reaching patients and their caregivers through various programs and services. We also take pride in personally showing up and participating in community events that support awareness, research and education for various types of cancer. Check out these “Team Taiho” photos from recent awareness and fundraising events across the U.S.
Within our Patient Alliances organization, we strive to understand the patient journey from diagnosis through treatment, incorporating the patient experience into the fabric of the company. We do this by actively engaging with patient advocacy organizations throughout clinical development and post-product launch to ensure we understand patient and caregiver perspectives and insights in the pursuit of advancing care. Additionally, Taiho provides funding support for patient and caregiver programs, initiatives, education and research.
LISTENING & LEARNING
Thank you, Chaundra (far left), and Melinda (second from left), for visiting Taiho on behalf of the Cholangiocarcinoma Foundation and sharing your insights and perspectives on this rare disease of the bile ducts of the liver. Your presentations as patients and advocates helped us better understand the patient journey and also provided impactful information on the valuable resources, education, support and research that personifies the work of patient advocacy organizations each and every day.